Mayo Clinic Laboratories and KYAN Technologies have announced a collaboration to validate and provide the KYAN test, Optim.AI, throughout the United States. This partnership seeks to offer clinicians enhanced testing insights for cancer treatment.
The collaboration combines Mayo Clinic Laboratories' expertise in advanced laboratory testing with KYAN Technologies' leadership in functional precision medicine for oncology. The initiative is expected to expand patients' access to cancer testing, offering new possibilities in the field of oncology.
